All publications

Carving out a Niche in Pharmaceutical Drug Delivery

  • Scientific publication

Pharma Times – Vol. 53 – No. 12  - Dec 2021

Ketkee Deshmukh, Agnivesh Shrivastava, Sunil Bambarkar

Download (.pdf - 319.91 KB)

A 3D-Printed Polymer–Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations

  • Scientific publication

Pharmaceutics 2021, 13, 2107 https://doi.org/10.3390/pharmaceutics13122107 - Dec 2021

Bryce W. Barber, Camille Dumont, Philippe Caisse, George P. Simon, Ben J. Boyd

Solubility and Stability of Delta-9-Tetrahydrocannabinol in Lipid Excipients

  • Poster

CRS Annual Meeting - virtual  - Jul 2021

V. Shankar, A. Shettar, P. Kolimi, I. Ellis, M. Dave, R. Murthy, S. Murthy

Download (.pdf - 248.3 KB)

Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 1 Studying impact on granule & tablet properties

  • Poster

CRS Annual Meeting - virtual  - Jul 2021

K. Deshmukh, A. Shrivastava, S. Banerjee, R. Tiwari, S. Bambarkar, N. Farah Gattefosse India Pvt. Ltd., Mumbai, INDIA, Gattefosse SAS, Lyon, FRANCE

Download (.pdf - 795.45 KB)

Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 2 Studying impact on dissolution profiles of ER tablets of different API’s

  • Poster

CRS Annual Meeting - virtual  - Jul 2021

K. Deshmukh1, A. Shrivastava1, S. Banerjee1, R. Tiwari1, S. Bambarkar1, N. Farah2 1Gattefosse India Pvt. Ltd., Mumbai, INDIA, 2Gattefosse SAS, Lyon, FRANCE

Download (.pdf - 832.93 KB)

Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 1 Studying impact on granule & tablet properties

  • Poster

CRS Annual Meeting - virtual - Jul 2021

K. Deshmukh, A. Shrivastava, S. Banerjee, R. Tiwari, S. Bambarkar, N. Farah Gattefosse India Pvt. Ltd., Mumbai, INDIA, Gattefosse SAS, Lyon, FRANCE

GELUCIRE® 4414 for type IV lipid based formulations and their in vitro in vivo performance evaluation

  • Poster

AAPS PharmSci360 – Philadelphia (USA)  - 2021

In this study, Gelucire® 44/14 in type IV lipid-based formulation has been evaluated to increase the solubility and in vivo performance of ticagrelor. 

Download (.pdf - 919.72 KB)

Solid lipid nanocarriers to increase oral bioavailability of the peptide Leuprolide

  • Poster

PBP World Meeting  - 2021

Camille Dumont, Vincent Jannin, Sandrine Bourgeois, Ana Beloqui, Véronique Préat, Hatem Fessi

Download (.pdf - 947.42 KB)

Formulation forum – A Quick Approach for Evaluation of Drug-Excipient Compatibility: Case of Acetylsalicylic Acid

  • Whitepaper

Drug Development & Delivery - 2021

Dr. Masumi Dave, Rollie Fuller

In this study, the authors monitor acetylsalicylic acid (ASA) hydrolysis in different formulations using UPLC and TAM with the objective of comparing these methods for agreement, speed, and efficiency in predicting drug stability. In parallel, we assess the impact of the excipient choices on the stability of the ASA.